Stellaromics today launched Pyxatm, the first commercially available platform to deliver multiplexed 3D spatial transcriptomics in intact tissue up to 100 micrometers thick. The launch marks a ...

Ahead of AGBT, Ultima Genomics launched its UG200 series touting smaller footprint, faster runtime, higher output, and lower pricing.

The launch marks a fundamental shift in spatial biology — from 2D thin-section approaches that analyze partial cell layers to true 3D analysis that preserves the native organization of cells, ...

Rare tumors, although individually uncommon, collectively account for a considerable proportion of cancer diagnoses and pose unique clinical and biological ...

IRB Barcelona has launched Spain’s first fully integrated spatial omics platform, allowing researchers to capture cells' ...

Bruker now extends their complete biology approach to mouse research by announcing development of the CosMx Mouse Whole ...

Researchers from the Department of Computer Science at Bar-Ilan University and from NVIDIA's AI research center in Israel ...

ArgenTag joins PacBio to enable instrument-free single-cell kits to support long-read isoform sequencing at single-cell ...

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Amyotrophic Lateral Sclerosis Therapeutics Market size & share revenue was ...

Danaher Corp. entered into a definitive agreement to acquire Masimo in an all-cash transaction valued at approximately $9.9 billion. Madrigal Pharmaceuticals signed an exclusive global license ...

Singular Genomics, a company delivering high-throughput spatial technologies to advance precision medicine, today announced the commercial launch and U.S. availability of G4X. The launch marks a major ...

What is the Market Size of Precision Medicine Research and Development Platform? The global market for Precision Medicine ...